Table 3.
Relative abundance of the most abundant bacterial phyla in the samples from STEC-infected and healthy subjects, obtained through analysis based on read mapping.
| A.9 (%) | A.8 (%) | A.14 (%) | A.40 (%) | A.41 (%) | A.32 (%) | A.4 (%) | A.16 (%) | 481-5 (%) | A.30 (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Actinobacteria | 0.5 | 1.1 | 6.3 | 56.2 | 14.8 | 50 | 14 | 3.5 | 28.5 | 0.8 |
| Proteobacteria | 15.7 | 56.6 | 13.3 | 1.9 | 3.4 | 1.6 | 29.5 | 12.2 | 1.6 | 3.7 |
| Bacteroidetes | 63.1 | 0.2 | 7.46 | 6.6 | 1 | 11 | 3.2 | 5 | 1.3 | 51 |
| Firmicutes | 19.7 | 41.3 | 71.2 | 34.2 | 79 | 36.7 | 52 | 76.4 | 66.5 | 16.7 |
| Verrucomicrobia | 0.16 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.3 | 27.5 |
Samples A.9, A.8, A.14 are from diseased patients; A.40, A.41, A.32 are from recovered patients; A.4, A.16, 481-5; A.30 are from healthy subjects.